Form 4: COMPASS Pathways CEO Sells Shares for Tax

Sentiment:

Insider Transaction Report


COMPASS Pathways plc CEO Kabir Nath reported the disposal of 16,181 ordinary shares to cover tax obligations related to restricted share unit vesting.

Summary

  • Kabir Nath, Chief Executive Officer and Director of COMPASS Pathways plc, reported a transaction involving the company's ordinary shares.
  • On February 2, 2026, 16,181 ordinary shares were disposed of.
  • The disposal was executed at a price of $6.61 per share.
  • This transaction was specifically to satisfy tax withholding obligations upon the vesting of restricted share units.
  • Following this reported transaction, Kabir Nath beneficially owns 205,121 ordinary shares.
  • The ordinary shares may be represented by American Depositary Shares (ADSs), with each ADS currently representing one ordinary share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine tax-related disposal of shares following RSU vesting, which is a common practice for executive compensation and does not indicate a change in company fundamentals or executive sentiment.

Positives

  • The transaction indicates the vesting of restricted share units (RSUs), which typically signifies the achievement of performance or time-based conditions by the executive.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine tax-related sales by executives, such as those to cover tax obligations upon the vesting of restricted share units, are a common and expected practice in executive compensation. This type of transaction typically does not signal a change in management's outlook on the company's prospects or underlying fundamentals.

Comparison to Industry Standards

  • StockSavvy.ai observes that this type of transaction is a common mechanism for executives to cover tax liabilities arising from equity compensation, aligning with standard corporate compensation practices across various industries. Companies like Pfizer (PFE) or Moderna (MRNA) frequently report similar Form 4 filings for their executives related to RSU vesting and tax withholdings, indicating this is a standard operational event rather than a discretionary sale.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a non-discretionary sale for tax purposes, not indicative of a change in executive confidence or company performance.
  • Employees: No direct impact.

Key Dates

DateDescription
02/02/2026Transaction Date: Disposal of 16,181 Ordinary Shares.
02/03/2026Signature Date of Reporting Person.

Recommendation

hold

This Form 4 reports a routine, non-discretionary sale of shares by the CEO to cover tax obligations upon RSU vesting. Such transactions are common and generally do not reflect a change in management's confidence or the company's fundamentals. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

COMPASS Pathways, CMPS, Kabir Nath, Form 4, Insider Transaction, Share Disposal, CEO, Restricted Share Units, RSU Vesting, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.